These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 12089861)
1. Multiple endocrine neoplasia 1--current recommendations for diagnosis and treatment. Kaczirek K; Prager G; Schindl M; Kaserer K; Gessl A; Vierhapper H; Niederle B Wien Klin Wochenschr; 2002 Apr; 114(7):258-66. PubMed ID: 12089861 [TBL] [Abstract][Full Text] [Related]
2. Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential? Dotzenrath C; Cupisti K; Goretzki PE; Yang Q; Simon D; Ohmann C; Röher HD Eur J Surg; 2001 Mar; 167(3):173-8. PubMed ID: 11316400 [TBL] [Abstract][Full Text] [Related]
3. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients. Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754 [TBL] [Abstract][Full Text] [Related]
4. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome. Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711 [TBL] [Abstract][Full Text] [Related]
5. Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1. Arnalsteen LC; Alesina PF; Quiereux JL; Farrel SG; Patton FN; Carnaille BM; Cardot-Bauters CM; Wemeau JL; Proye CA Surgery; 2002 Dec; 132(6):1119-24; discussion 1124-5. PubMed ID: 12490864 [TBL] [Abstract][Full Text] [Related]
6. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Westerdahl J; Bergenfelz A Ann Surg; 2007 Dec; 246(6):976-80; discussion 980-1. PubMed ID: 18043099 [TBL] [Abstract][Full Text] [Related]
7. Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Pieterman CR; van Hulsteijn LT; den Heijer M; van der Luijt RB; Bonenkamp JJ; Hermus AR; Borel Rinkes IH; Vriens MR; Valk GD; Ann Surg; 2012 Jun; 255(6):1171-8. PubMed ID: 22470073 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis and surgical treatment of multiple endocrine neoplasia. Zhou GW; Wei Y; Chen X; Jiang XH; Li XY; Ning G; Li HW Chin Med J (Engl); 2009 Jul; 122(13):1495-500. PubMed ID: 19719936 [TBL] [Abstract][Full Text] [Related]
9. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Bartsch DK; Langer P; Wild A; Schilling T; Celik I; Rothmund M; Nies C Surgery; 2000 Dec; 128(6):958-66. PubMed ID: 11114630 [TBL] [Abstract][Full Text] [Related]
10. Management of nonfunctioning pancreatic endocrine tumors in the context of multiple endocrine neoplasia type 1 syndrome. Botsios D; Vasiliadis K; Tsalis K; Iordanidis F; Megalopoulos A; Tsachalis T; Blouhos K; Betsis D J Gastrointestin Liver Dis; 2007 Sep; 16(3):257-62. PubMed ID: 17925918 [TBL] [Abstract][Full Text] [Related]
11. Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1. Hubbard JG; Sebag F; Maweja S; Henry JF Arch Surg; 2006 Mar; 141(3):235-9. PubMed ID: 16549687 [TBL] [Abstract][Full Text] [Related]
12. [Diagnosis, therapy and screening of multiple endocrine neoplasia type I (MEN I) in four endocrinologic centers]. Schaaf L; Nies G; Raue F; Tuschy U; Seif FJ; Trojan J; Usadel KU Med Klin (Munich); 1994 Jan; 89(1):1-6. PubMed ID: 7908402 [TBL] [Abstract][Full Text] [Related]
14. Genetic screening for MEN1 mutations in families presenting with familial primary hyperparathyroidism. Perrier ND; Villablanca A; Larsson C; Wong M; Ituarte P; Teh BT; Clark OH World J Surg; 2002 Aug; 26(8):907-13. PubMed ID: 12016470 [TBL] [Abstract][Full Text] [Related]
15. Surgical management of MEN-1 and -2: state of the art. Akerström G; Stålberg P Surg Clin North Am; 2009 Oct; 89(5):1047-68. PubMed ID: 19836484 [TBL] [Abstract][Full Text] [Related]
16. Enucleation and limited pancreatic resection provide long-term cure for insulinoma in multiple endocrine neoplasia type 1. Bartsch DK; Albers M; Knoop R; Kann PH; Fendrich V; Waldmann J Neuroendocrinology; 2013; 98(4):290-8. PubMed ID: 24356648 [TBL] [Abstract][Full Text] [Related]
17. Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A. Asari R; Scheuba C; Kaczirek K; Niederle B Arch Surg; 2006 Dec; 141(12):1199-205; discussion 1205. PubMed ID: 17178962 [TBL] [Abstract][Full Text] [Related]
18. Adrenal involvement in multiple endocrine neoplasia type 1. Langer P; Cupisti K; Bartsch DK; Nies C; Goretzki PE; Rothmund M; Röher HD World J Surg; 2002 Aug; 26(8):891-6. PubMed ID: 12016472 [TBL] [Abstract][Full Text] [Related]
19. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744 [TBL] [Abstract][Full Text] [Related]
20. Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1. Mortellaro VE; Hochwald SN; McGuigan JE; Copeland EM; Vogel SB; Grobmyer SR Am Surg; 2009 Aug; 75(8):730-3. PubMed ID: 19725300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]